Transcriptional network underlying Caenorhabditis elegans vulval development by Inoue, Takao et al.
Transcriptional network underlying Caenorhabditis
elegans vulval development
Takao Inoue, Minqin Wang, Ted O. Ririe, Jolene S. Fernandes, and Paul W. Sternberg*
Division of Biology and Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125
Edited by Eric H. Davidson, California Institute of Technology, Pasadena, CA, and approved February 1, 2005 (received for review November 11, 2004)
The vulval development of Caenorhabditis elegans provides an
opportunity to investigate genetic networks that control gene
expression during organogenesis. During the fourth larval stage
(L4), seven vulval cell types are produced, each of which executes
a distinct gene expression program. We analyze how the expres-
sion of cell-type-specific genes is regulated. Ras and Wnt signaling
pathways play major roles in generating the spatial pattern of cell
types and regulate gene expression through a network of tran-
scription factors. One transcription factor (lin-29) primarily controls
the temporal expression pattern. Other transcription factors (lin-
11, cog-1, and egl-38) act in combination to control cell-type-
specific gene expression. The complexity of the network arises in
part because of the dynamic nature of gene expression, in part
because of the presence of seven cell types, and also because there
are multiple regulatory paths for gene expression within each cell
type.
organogenesis  signaling pathways  transcription
Developmental events are driven by spatially and temporallyregulated gene expression. Understanding how complex
patterns of expression are produced is therefore a critical part of
deciphering mechanisms of development. In general, intercel-
lular signaling mechanisms interact with a network of transcrip-
tion factors to generate cell-type-specific patterns of gene ex-
pression. The late stage of Caenorhabditis elegans vulval
development offers a useful model in which to study this process.
During this period of vulval development, seven distinct cell
types are produced that express unique combinations of genes.
Over the last several years, a number of genes were discovered
that are expressed in cell-type and stage-specific patterns in the
vulva, and several transcription factors were found to regulate
these genes. In this paper, we synthesize and extend our current
knowledge of this genetic network.
TheC. elegans vulva connects the uterine lumen to the outside,
allowing for passage of sperm and fertilized eggs (1). Vulval cells
are generated postembryonically from precursor cells P3.p P4.p,
P5.p, P6.p, P7.p, and P8.p [also called vulval precursor cells
(VPC)]. During the mid-third larval (L3) stage, EGF and Notch
signaling induces the middle three VPCs (P5.p, P6.p, and P7.p)
to adopt vulval fates, whereas P3.p, P4.p, and P8.p fuse with the
hypodermal syncytium, hyp7 (2–6).
During the late-L3 to the early-L4 stage, P5.p, P6.p, and P7.p
undergo two or three rounds of cell division to produce 22 nuclei
(7) (Fig. 1A). These nuclei are in cells of seven types (vulA,
vulB1, vulB2, vulC, vulD, vulE, and vulF), as evidenced by
subsequent morphogenetic movements and by the pattern of
gene expression (8, 9) (Fig. 1B). The seven cell types that are
present in the adult vulva represent specializations within the
general epithelial cell class. These cells exhibit cell-type general
features; for example, each expresses ajm-1, a component of the
apical junction that connects neighboring cells in epithelial
tissues (8). However, in addition, each cell type exhibits func-
tional specializations: vulF cells, which form the innermost
section of the vulva, connect directly with cells of the uterus. vulE
cells form structural attachments to lateral hypodermal (seam)
cells. vulC and vulD cells attach to vulval muscles that open the
vulva for the passage of eggs. vulA cells form attachment to the
hyp7 syncytium. It is expected that gene expression differences
underlie these specializations.
Here, we are concerned with the execution of cell-type-
specific gene expression programs during the late L3 and L4
stages, mostly after the terminal division of vulval cells. During
this period, each cell type exhibits a cell-type-specific pattern of
gene expression, and several transcription factors are known that
regulate the expression of these cell-type-specific genes. We
bring together our current knowledge of this system to produce
the framework in which to investigate the gene regulatory
network controlling vulval organogenesis.
Materials and Methods
Determination of Gene Expression Patterns. Essentially all gene
expression analyses described in this paper (including data from
other papers) were carried out by using gfp reporter transgenes.
For all results, it is possible that reporter expression does not
accurately reflect the expression pattern of the endogenous
gene. For simplicity, we refer to the reporter by the correspond-
ing gene name.
The expression pattern of C55C3.5 was determined by using
gfp reporter clone pUL#G221N (I. Hope, personal communi-
cation). This plasmid was injected into unc-119(ed4) animals by
using the plasmid pDP#MM016B [unc-119()] as a coinjection
marker (10). Of genes listed in Fig. 1B and in the main text, we
have not examined the expression pattern of syg-2, bam-2, and
sqv-4. Because GFP is likely to be stable for many hours, the time
at which expression is turned off is not reliably indicated by
decreased GFP expression. For most genes we analyzed, GFP
fluorescence persists into the adult stage.
Genotypes. For Tables 1–3, gfp reporter transgenes used were
ayIs4[egl-17::gfp], syIs50[cdh-3::gfp], syIs49[zmp-1::gfp], and
syIs54[ceh-2::gfp] (9). The egl-26::gfp transgenic line analyzed
was kuIs36 (11). Mutations used are; cog-1(sy275), cog-1(sy607),
lin-29(sy292), lin-11(n389), and egl-38(n578). Of two cog-1 tran-
scripts, the longer cog-1A transcript contains a corepressor-
binding domain, whereas the shorter cog-1B transcript does not
(12). sy275 is a missense mutation predicted to affect both
transcripts. sy607 is a deletion that eliminates the cog-1A tran-
script. The two alleles exhibit complementary defects in vulval
development (13). Although both alleles are recessive, it is not
known whether the loss of cog-1 function causes observed
phenotypes. lin-29(sy292) and lin-11(n389) are strong loss-of-
function alleles, and egl-38(n578) is a reduction-of-function
allele. Strains were constructed by using standard methods.
Results and Discussion
Vulval Cell-Type-Specific Gene Expression. A number of genes are
expressed in specific subsets of vulval cells (Fig. 1B). Previously
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described genes of this type include cdh-3 (14), egl-17 (15), lin-3
(16), zmp-1 (9, 17), ceh-2 (9), T04B2.6 (9), F47B8.6 (9), B0034.1
(9), unc-53 (18), egl-26 (11), sqv-4 (19), bam-2 (20), and syg-2
(21). egl-26 was previously reported to express in vulE and vulB2
cells (11). We found that a nuclear-localized egl-26::gfp tran-
scriptional fusion expressed in vulB1, vulB2, vulD, and vulE cells
(Materials and Methods). The expression was somewhat variable
and was observed starting from the mid-L4 stage and continuing
Fig. 1. The pattern of gene expression during late stages of vulval development. (A) An overview of vulval development. Lineal origins of 22 vulval nuclei are
indicated. ‘‘ABCDEFFEDCBA’’ refer to vulval cell types vulA, vulB1, vulB2, vulC, vulD, vulE, and vulF. vulB is the only case in which a single VPC granddaughter
gives rise to two cell types (8). Vulval cell nuclei at each stage are positioned as indicated (left, anterior; right, posterior). (B) A summary of cell-type specificity
and timing of expression in the wild type (Materials andMethods) (9, 11, 13–21, 24–26). Boxes indicate stages at which gene expression is activated. The vertical
order of events within each time block is arbitrary. For egl-17, vulEvulF expression begins in P6.p (early L3) and persists in their descendants (vulE and vulF) until
turned off in the early L4 stage. This inactivation, which is regulated by lin-29 and lin-11, is indicated by the box marked ‘‘egl-17 OFF.’’ ceh-2 is expressed at a
higher level in vulB1 compared with vulB2. (C) Expression pattern of lin-11. The diagrammed pattern is based on the lin-11::gfp transgene syIs80 (26). (D)
Expressionpatternof cog-1.Thepattern is basedon the cog-1::gfp transgene syIs63 (13). (E) Thealteredpatternofgeneexpression in lin-29mutants (9, 23) (Tables
1 and 2). White boxes with the red outlines indicate loss of expression and loss of egl-17 down-regulation in the lin-29mutant. lin-29 appears to regulate events
that occur during the mid-L4 to the late L4 stage. (F) The altered pattern of gene expression in cog-1 mutants (Table 3 and Fig. 2). Arrows are drawn with the
assumption that both sy607 and sy275 phenotypes are caused by different reduction of function of the cog-1 gene. Filled boxes with red or blue outline indicate
ectopic expression. (G) Altered pattern of gene expression in lin-11mutants (26). (H) Altered pattern of gene expression in the egl-38mutant (16) (Tables 1 and
2). egl-17 expression in vulF is observed in the cog-1(sy275); egl-38 double mutant, suggesting a redundant repression mechanism.






















into the adult stage. The C55C3.5 gene encoding a novel protein
was previously found to express in vulval cells (I. Hope, personal
communication). We found that C55C3.5::gfp was expressed in
vulF cells, starting from the late-L4 and continuing into the adult
stage.
Several conclusions can be drawn from Fig. 1B. First, all seven
cell types exhibit distinct programs of gene expression, despite
the fact that these cells are related by cell lineage and function.
[vulB1 and vulB2 differ in the level of ceh-2 expression but
otherwise have similar expression profiles (9)]. Distinct expres-
sion profiles likely underlie distinct functions of vulval cell types.
For example, lin-3, which encodes an EGF-related signaling
protein, is expressed in vulF cells in the mid-L4 stage (16). This
signal is required for a vulva-to-uterus signaling that induces a
specific fate, uv1, in uterine cells adjacent to vulF.
The pattern of marker expression also reveals a strict temporal
regulation of gene expression (Fig. 1B). For example, cdh-3 is
expressed in early L4, F47B8.6 is expressed in late L4, and
T04B2.6 is expressed 1 day after the L4-to-adult molt (9). For
egl-17, ceh-2, zmp-1, and sqv-4, the timing of gene expression is
different for different vulval cells (9, 15, 19). For example, egl-17
is expressed in vulE and vulF cells in the L3 stage and in vulC
and vulD in the L4 stage.
Trans-Regulation of Vulva Gene Expression. The analysis of the
regulatory network controlling the pattern of gene expression in
the vulva has focused primarily on the effect of transcription
factor mutations on gene expression reporter transgenes. Inmost
cases, a direct transcriptional regulation of the target has not
been demonstrated. Key results are summarized in Fig. 1 E–H.
So far, important regulators are lin-29 (encoding Zn-finger
transcription factor; Fig. 1E) (9, 22, 23), cog-1 (Nkx6 homeodo-
main; Fig. 1 D and F) (13), lin-11 (LIM homeodomain; Fig. 1 C
and G) (24–26), and egl-38 (PAX 258; Fig. 1H) (16, 27).
A Temporal Regulator of Gene Expression. lin-29 is required for the
expression of egl-17 in vulC and vulD (23), ceh-2 in vulC (9), and
zmp-1 in vulD and vulE (Fig. 1E, Tables 1 and 2, and Fig. 5, which
is published as supporting information on the PNAS web site)
(9). By contrast, lin-29 in not required for the expression of cdh-3
in vulC, vulD, vulE, vulF (9), ceh-2 in vulB (9), egl-17 in vulE and
vulF (23), and zmp-1 in vulA (9). Moreover, the expression of
egl-17 in vulE and vulF is observed during the L4 stage (23),
suggesting that the mechanism that turns off egl-17 expression in
these cells is compromised (Fig. 5). These lin-29 phenotypes are
not easily explained by cell fate changes between vulval cell types
but suggest a temporal regulatory defect: lin-29 mutations cause
loss of events associated with themid-to-late L4 time points. This
interpretation of these data is particularly attractive, because
lin-29 mutations are known to cause heterochronic defects in
other tissues, specifically in the L4-to-adult transition in the
lateral hypodermis (22, 28, 29). lin-29 is expressed in all vulval
cells, starting in the mid-L3 stage and continuing through the L4
stage (30).
Cell-Type-Specific Regulators of Gene Expression. We analyzed the
effect of two cog-1 (Nkx6.16.2 homeodomain) mutations on the
expression of vulval-cell-specific gene expression reporters (Fig.
1F, Table 3, and Materials and Methods). cog-1(sy275) is a
missense mutation in the homeodomain, and cog-1(sy607) is a
small deletion that eliminates one of two cog-1 transcripts (13).
We found that in the mid-L4 stage, cog-1(sy275) caused ectopic
expression of egl-17 in vulE cells (Fig. 2) and ectopic expression
of ceh-2 in vulC, vulD, and vulE cells and loss of zmp-1 expression
in vulE cells. In contrast, cog-1(sy607) caused loss of cdh-3
expression in vulC, vulD, and vulE cells and loss of ceh-2
expression in vulB. These results indicate that egl-17, cdh-3,
ceh-2, and zmp-1 are regulated by the cog-1 gene. Although some
cog-1 expression is observed in all vulval cells, gfp reporters
suggest that cog-1 is most strongly expressed in vulC and vulD
and weakly in vulE and vulF, implying a cell-type-specific
function (13) (Fig. 1D).
A somewhat similar situation is presented with lin-11 (LIM-
homeodomain) (Fig. 1 C and G). During the L4 stage, lin-11 is
expressed strongly in vulB, vulC, and vulD and weakly in other
vulval cells, suggesting that lin-11 is involved in the specification
of these cell types (24, 26). However, unexpectedly, lin-11 is
cell-autonomously required for expression of most vulval genes
tested, including in cells where the lin-11 level is low (26).
egl-38 is a PAX258 transcription factor required for expres-
Table 3. Expression of egl-17, ceh-2, and cdh-3 in cog-1 mutants
Reporter Mutations vulA
vulB1 and
vulB2 vulC vulD vulE vulF
egl-17  0 0 100 100 0 0
egl-17 cog-1 (sy275) 0 0 100 92 92 0
egl-17 cog-1 (sy607) 0 0 93 100 0 0
ceh-2  0 100 0 0 0 0
ceh-2 cog-1 (sy275) 20 90 80 80 88 0
ceh-2 cog-1 (sy607) 0 0 0 0 0 0
cdh-3  0 0 100 100 100 100
cdh-3 cog-1 (sy275) 0 0 100 100 100 100
cdh-3 cog-1 (sy607) 0 0 14 14 71 94
Percentagesof cells inmid-L4animals that expressedegl-17::gfp, ceh-2::gfp
and cdh-3::gfp. See Table 4, which is published as supporting information on
the PNAS web site, for number of cells scored.
Table 1. Expression of zmp-1 in vulE and vulF cells
Genotype vulE vulF No. of animals
Wild type   80
lin-11   55*
lin-29   50†
cog-1 (sy275)   52
egl-38   48
lin-11; egl-38   52
lin-29; egl-38   56
cog-1; egl-38   56
*Ref. 26.
†Ref. 9.




Wild type   59
cog-1 (sy275)   46
egl-38   38
cog-1; egl-38   37
lin-11 —* —* 45†
lin-29 —* —* 43‡
lin-11; lin-29 —* —* 38
lin-11; cog-1 —* —* 43
lin-29; cog-1 —* —* 40
lin-11; cog-1; egl-38 —* —* 35
lin-29; cog-1; egl-38 —* —* 36
*These cells express egl-17::gfp at a low level. We interpret these as the
persistence of L3 expression.
†Ref. 26.
‡Ref. 23.
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sion of the lin-3 gene in vulF cells (16, 27). We found that egl-38
represses expression of zmp-1 in vulF cells, indicated by ectopic
zmp-1 expression in egl-38 mutants (Fig. 1G and Table 2). In
addition, in an egl-38; cog-1 double mutant, egl-17 is expressed in
both vulE and vulF cells. Thus, egl-38 is also capable of repressing
egl-17 expression in vulF cells, although in the wild type, this
function is redundant with the cog-1-dependent mechanism that
restricts egl-17 expression to vulC and vulD. egl-38 is currently the
best example of cell-type-specific factors, promoting expression
of some genes (lin-3) and repressing expression of others (zmp-1,
egl-17) in a single cell type, vulF.
Regulators of the Transcription Factor Network. The transcription
factor network that regulates gene expression in individual cell
types must be regulated by the cell-fate-patterning mechanism
that specifies each cell to a specific fate and does so in a spatially
precise pattern. In the vulva, the cell types occur in a specific
ABCD-EFFE-DCBA pattern (Fig. 1A). Although the full mech-
anism that establishes this pattern is not known, Wnt signals,
mediated by lin-17 (Frizzled-type Wnt receptor) and lin-18
(Ryk-typeWnt receptor), control the anteriorposterior order of
cell types among P7.p descendants (31, 32) (Fig. 3). Analysis of
cog-1 (31) and lin-11 (25) expression in lin-17 and lin-18mutants
indicates that Wnt signaling establishes the correct spatial pat-
tern of transcription factor expression. As described above
(Tables 1 and 3 and Fig. 1 F andG) (26), cog-1 and lin-11, in turn,
control the expression pattern of egl-17 and cdh-3. Patterns of
egl-17 and cdh-3 expression observed in lin-17 and lin-18mutants
are consistent with high levels of cog-1 and lin-11 turning on the
expression of these genes (31, 32). Another set of cell-fate-
patterning mechanisms controlling gene expression was revealed
by the analysis of vulE vs. vulF fate specification using the zmp-1
reporter. A dominant-negative Ras or the ablation of the anchor
cell disrupts the pattern of zmp-1 expression in presumptive vulE
and vulF cells, indicating that a Ras-mediated signal, probably
from the anchor cell, establishes the spatial pattern of cell
fates (17).
These results confirm that cell–cell communication is impor-
tant in patterning cell fates, and that signaling pathways operate
through the transcription factor network to control the pattern
of gene expression. Expression patterns of various genes (Fig. 1
B–D) suggest that transcription factors are expressed in all vulval
cells at different levels, whereas genes regulated by them have
relatively simple onoff patterns of expression. This difference
suggests that the spatial pattern becomes progressively more
refined as the information is passed through the regulatory
network. This progressive refinement of pattern is likely a
consequence of integration of information from multiple regu-
latory mechanisms, such as intercellular communication and
feedback regulation. Many of these disparate data inputs are
likely processed at the level of cis-regulatory modules. Thus, the
Fig. 2. Regulation of egl-17 by cog-1. (A and B) Nomarski and epifluores-
cence images of wild-type mid-L4 animal carrying the egl-17::gfp transgene.
Arrows point to vulE nuclei. vulE cells are not fluorescent. (C and D) cog-
1(sy275) animals at the same stage carrying the egl-17::gfp transgene. vulE
cells are fluorescent.
Fig. 3. Link between cell fate patterningmechanisms andgene expression. In general, inductive signals regulate transcription factor networks to regulate gene
expression. In the P7.p (but not P5.p) lineage, Wnt signals transduced by lin-17 and lin-18 control the pattern of cog-1 and lin-11 expression (25, 31). cog-1 and
lin-11 in turn regulate egl-17 and cdh-3 expression (Table 3) (26). It has not been determined whether cog-1 and lin-11 regulate each other. In the P6.p lineage,
an anchor cell signal anda let-60Ras signal transductionpathway are required to establish the correct patternof zmp-1 expressionpattern (17). zmp-1 expression
is also repressed in vulF by egl-38 PAX258 (Table 1). It is not known whether the patterning mechanism acts through egl-38. The expression pattern of egl-38
is also not known.






















spatial pattern of transcription factor effects becomes more
restricted than the spatial pattern of transcription factor expres-
sion. This hypothesis is consistent with the observation that cells
affected by lin-11 and cog-1mutations do not correspond directly
to cells that express high levels of lin-11 and cog-1.
cis-Regulation of Vulva Gene Expression. cis-regulatory elements
(e.g., enhancers) have been analyzed in detail for several genes
expressed in the vulva, most notably egl-17, cdh-3, and zmp-1,
using transgenic assays (33, 34). A comparative genomics anal-
ysis of the regulatory region of orthologs from C. elegans and
Caenorhabditis briggsae has also proved useful.
Here, we focus on the analysis of the egl-17 gene. As shown in
Fig. 1B, this gene is expressed in vulE and vulF cells during the
L3 stage and in vulC and vulD cells during the L4 stage.
Dissection of the 5 regulatory region revealed that there are
three separable enhancer elements, two driving expression in
vulE and vulF and one driving expression in vulC and vulD (33,
34) (Fig. 4A). Notably, each of these elements drives expression
at different times. The distal vulEvulF element drives expres-
sion in the mid-L3 to early-L4 and the proximal vulEvulF
element drives expression in the early to mid-L3 stage (34). The
vulDC element drives expression in the mid-L4 stage. Thus, the
expression of egl-17 is produced by the composite activity of
three discrete enhancers, each of which drives both spatially and
temporally restricted pattern of expression. We propose two
models for how the information that operates on these enhancers
is integrated. In one model (Fig. 4B), temporal (blue) and spatial
(red) regulators both bind directly to the egl-17 promoter, and
information integration is achieved directly on the cis-regulatory
element. Alternatively, transcription factors that bind to each of
these promoters may already combine temporal and spatial
information (Fig. 4C). Our results indicate that the vulDC
element regulating mid-L4 expression is likely regulated by
lin-29, lin-11, cog-1, and egl-38. Additional experiments are
necessary to determine the molecular mechanism of information
integration.
Conclusion
The late vulval development of C. elegans offers an excellent
system in which to investigate cell fate determination and
regulation of cell-type-specific gene expression. In particular,
this system combines single-cell resolution with a high degree
of temporal resolution in an easily manipulated model organ-
ism. In many respects, vulval development is reminiscent of
other systems in that transcription factors are expressed in
overlapping domains, and the identity of each domain is
established combinatorially by the presence or absence of
specific subsets of these transcription factors. One interesting
example with possible parallels to the vulva is the fate-
specification mechanism in the vertebrate ventral neural tube
(35). In this system, Nkx6.1 and Nkx6.2 homeodomain proteins
(homologs of cog-1) interact with transcription factors Dbx1
and Dbx2 in a mutually repressive network, and different
activities of repressor proteins help establish the spatial pat-
tern of cell fates (36, 37). It is possible that C. elegans cog-1
functions in a similar manner in the vulva.
Analysis of vulval development also highlights several features
that are not necessarily evident in other systems. First, analysis
of vulval development has revealed a highly complex pattern of
temporal regulation, which is undoubtedly a feature of most
organogenetic processes (for example, see refs. 38 and 39). The
involvement of lin-29, a known regulator of stage-specific de-
velopment in C. elegans, suggests that the global mechanism of
temporal regulation feeds into the development of this particular
organ. Additional mechanisms probably exist that control ex-
pression at other time points. Whether these other time points
are regulated by a global mechanism or in an organ-autonomous
manner is not yet clear.
One concept that has been invoked in analyses of cell or organ
fate specification is that of ground state and selector genes. For
example, in Drosophila appendage development, it has been
proposed that a default ‘‘ground state’’ exists and is modified by
‘‘selector’’ genes to produce an antenna or a leg (40). The
concept can be applied to the level of individual cell types as well
(for example, ref. 41). From this point of view, the cell-type-
specific transcription factors cog-1, lin-11, and egl-38 can be
thought of as selector genes for subsets of vulval cell types. What
is the ground state of vulval cells in the absence of selector genes?
A cell in such a state presumably will not express the cell-type-
specific genes described in Fig. 1 but will retain the epithelial
identity common to all vulval cells. It is unclear whether such a
state has been observed in any of the mutants. Vulval cells in
lin-11 mutants lack most cell-type-specific expression but retain
the ability to undergo some morphogenetic movements charac-
teristic of vulval cells and thus may most closely resemble the
ground state.
In other systems, analyses of coregulated genes have suc-
cessfully identified ‘‘gene batteries’’ (42), sets of genes with
common cis-regulatory elements that are coexpressed (for
example, ref. 43). However, our understanding of vulval
development is still limited, relative to the number of cell types
Fig. 4. cis-regulatory elements of egl-17. (A) A map of the egl-17 5 regula-
tory region. Boxes indicate enhancer elements defined by Cui and Han (34)
and Kirouac and Sternberg (33). ‘‘AND’’ and ‘‘OR’’ logic gate symbols indicate
sites and logic of information integration. Temporal (blue) and spatial (red)
information is integrated as indicated by the logic circuit diagram to produce
the complete egl-17 expression pattern. In one model (B), spatially and
temporally regulated transcription factors each bind directly to the egl-17
cis-regulatory region. The integration of information takes place on enhancer
elements. In the alternative model (C), spatial and temporal cues are inte-
grated at the transcription factor level. These transcription factors (purple)
with both spatially and temporally restricted activity regulate each enhancer
element.
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and the number of distinct stages that require different gene
expression patterns. Consequently, within the relatively small
number of functionally unrelated genes analyzed so far, genes
are more likely to be regulated by distinct mechanisms. Thus,
although gene batteries with multiple genes probably exist in
this system, their analysis requires knowledge of more genes
and a detailed understanding of which transcription factors
regulate their expression.
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